DWAYNE LABATUT: Open Payments
NPI 1760462782 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 53 payments from 15 companies in 2025. Trend: 2023 $836 · 2024 $733 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $231 |
| GlaxoSmithKline, LLC. | 11 | $205 |
| Astellas Pharma US Inc | 7 | $161 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Antares Pharma, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
Products named: TRELEGY ELLIPTA, Veozah, UBRELVY, VRAYLAR, FANAPT, Auvelity, XYOSTED, QULIPTA.
Industry payments across LA — which companies pay providers there.
